Text Registration
Copyright Title
Clinical Practice Guideline: Biosimilars (2018)
Status
Published
on 20 Dec 2018
Year of Creation
2018
Copyright Claimant
United Rheumatology, LLC
Registration Number
TX0008679160
on 20 Dec 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008679160) dated 20 Dec 2018, pertains to an electronic file (eService) titled "Clinical Practice Guideline: Biosimilars (2018)" created in 2018. The copyright holder is United Rheumatology, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to United Rheumatology, LLC.
Application Details
Registration Number
TX0008679160
Registration Date
12/20/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
United Rheumatology, LLC
Physical Description
Electronic file (eService)
First Publication Nation
United States
Preexisting Material
text, Version 1.1.2017
Notes
Material Matter Claimed Note: text
Statements
Application Title Statement: Clinical Practice Guideline: Biosimilars (2018)
Author Statement: United Rheumatology, LLC employer for hire Domicile: United States Citizenship: United States Authorship: text Alan Epstein 1953 Citizenship: United States Authorship: text Joe Huffstetter 1954 Citizenship: United States Authorship: text Alan Gibofsky 1949 Citizenship: United States Authorship: text Shelley Weiner 1947 Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.